Get Live Data

Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

  2. Share Prices
  3. Indivior Share Price
  4. Indivior Share Regulatory News
  5. Total Voting Rights

Pin to quick picksIndivior Regulatory News (INDV)

Indivior Information

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Sep 2022 09:44

RNS Number : 9327X
Indivior PLC
01 September 2022
 

INDIVIOR PLC (THE 'COMPANY')

TOTAL VOTING RIGHTS AND CAPITAL

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at September 1, 2022 the Company's issued share capital consisted of 692,075,289 Ordinary Shares of US$0.10 each. The Company does not hold any shares in Treasury.

 

Therefore, the total number of voting rights in the Company is 692,075,289. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Kathryn Hudson

Company Secretary

 

September 1, 2022

 

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUASWRUUUKRRR
151617181920212223
Date   Source Headline
1st Jul 20197:00 amRNSTotal Voting Rights
25th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 201912:31 pmRNSIndivior Presents RECOVER Study Data at CPDD 2019
14th Jun 20198:47 amRNSHolding(s) in Company
29th May 20197:00 amRNSHolding(s) in Company
24th May 20199:04 amRNSHolding(s) in Company
17th May 20199:55 amRNSHolding(s) in Company
16th May 20197:00 amRNSIndivior to Participate in Conference
15th May 20197:00 amRNSDirector/PDMR Shareholding
13th May 20193:43 pmRNSDirector/PDMR Shareholding
13th May 20197:00 amRNSHolding(s) in Company
13th May 20197:00 amRNSHolding(s) in Company
9th May 201911:30 amRNSLicensing of PERSERIS in Canada
9th May 201910:29 amRNSBlock listing Interim Review
8th May 20191:54 pmRNSResult of AGM
3rd May 20197:00 amRNSHolding(s) in Company
2nd May 201912:00 pmRNS1st Quarter Results
2nd May 20197:00 amRNSHolding(s) in Company
1st May 20199:56 amRNSHolding(s) in Company
29th Apr 20194:16 pmRNSHolding(s) in Company
29th Apr 20191:35 pmRNSHolding(s) in Company
29th Apr 20191:25 pmRNSHolding(s) in Company
29th Apr 20191:16 pmRNSHolding(s) in Company
18th Apr 20199:24 amRNSChange of Registered Office
17th Apr 20193:26 pmRNSHolding(s) in Company
10th Apr 20197:00 amRNSStatement of Indivior on Grand Jury Indictment
9th Apr 20197:00 amRNSHolding(s) in Company
8th Apr 20199:18 amRNSIndivior publishes new research on opioid use disorder
8th Apr 20197:00 amRNSIndivior Presents RECOVER Study Data at ASAM 2019
5th Apr 20191:30 pmRNSIndivior Announces New Data at ASAM Conference
4th Apr 20197:00 amRNSNotice of Results
3rd Apr 201910:38 amRNSHolding(s) in Company
18th Mar 20194:27 pmRNSHolding(s) in Company
15th Mar 20195:00 pmRNSHolding(s) in Company
14th Mar 20192:00 pmRNSAnnual Financial Report
8th Mar 20192:30 pmRNSDirectorate Change
7th Mar 20192:00 pmRNSPatient-centered Outcomes Published
6th Mar 201910:37 amRNSDirector/PDMR Shareholding
4th Mar 20194:54 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSTotal Voting Rights
28th Feb 20193:31 pmRNSHolding(s) in Company
27th Feb 20191:00 pmRNSIndivior Launches PERSERIS (risperidone)
26th Feb 20193:10 pmRNSDirector Declaration
20th Feb 20199:06 amRNSHolding(s) in Company
20th Feb 20197:00 amRNSIndivior Launches SUBOXONE Film Authorized Generic
19th Feb 20197:00 amRNSThe Lancet Publishes Phase 3 Results of SUBLOCADET
14th Feb 20197:00 amRNSFinal Results
12th Feb 20197:00 amRNSFederal Court Denies Motion to Stay
5th Feb 20197:00 amRNSIndivior Responds to CAFC Rehearing Decision
4th Feb 20197:05 amRNSIndivior Enters into Agreement with Alvogen
151617181920212223

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.